Amalgamated Bank Nuvectis Pharma, Inc. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
SELL
$6.69 - $11.0 $4,943 - $8,129
-739 Reduced 76.19%
231 $2,000
Q4 2023

Feb 06, 2024
SELL
$7.85 - $11.78 $541 - $812
-69 Reduced 6.64%
970 $8,000
Q2 2023

Aug 11, 2023
BUY
$12.62 - $18.4 $13,112 - $19,117
1,039 New
1,039 $16,000

Others Institutions Holding NVCT

# of Institutions
32
Shares Held
1.65M
Call Options Held
0
Put Options Held
0
View Full List

About Nuvectis Pharma, Inc.

NVCT Quotes by TradingView
  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $68.8M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email